Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru
Authors:
Open Access
- 27 September 2001
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (9) , 1409-1415
Abstract
Background: Enteric infection by Giardia intestinalis is a common cause of diarrhoea world‐wide and a significant cause of morbidity in children.Aim: To compare the efficacy and safety of nitazoxanide and metronidazole in the treatment of diarrhoea caused by G. intestinalis in children.Methods: A total of 110 children presenting with diarrhoea caused by G. intestinalis were randomized to treatment with either a 3‐day course of nitazoxanide (100 mg b.d., age range 2–3 years; 200 mg b.d., age range 4–11 years) or a 5‐day course of metronidazole (125 mg b.d., age range 2–5 years; 250 mg b.d., age range 6–11 years). The patients were followed‐up for a determination of clinical response 7 days after the initiation of treatment, and two subsequent stool samples were collected for parasitological examination.Results: Diarrhoea had resolved in 47 children out of 55 (85%) in the nitazoxanide treatment group before the day 7 follow‐up visit, compared to 44 out of 55 (80%) for metronidazole. Diarrhoea resolved within 4 days in most cases. Only mild, transient adverse events were reported.Conclusions: A 3‐day course of nitazoxanide suspension is as efficacious as a standard 5‐day course of metronidazole suspension in treating giardiasis in children.Keywords
This publication has 27 references indexed in Scilit:
- Treatment of Diarrhea Caused byGiardia intestinalisandEntamoeba histolyticaorE. dispar:A Randomized, Double‐Blind, Placebo‐Controlled Study of NitazoxanideThe Journal of Infectious Diseases, 2001
- Treatment of Diarrhea Caused byCryptosporidium parvum:A Prospective Randomized, Double‐Blind, Placebo‐Controlled Study of NitazoxanideThe Journal of Infectious Diseases, 2001
- Successful Treatment of Metronidazole‐ and Albendazole‐Resistant Giardiasis with Nitazoxanide in a Patient with Acquired Immunodeficiency SyndromeClinical Infectious Diseases, 2001
- Treatment of GiardiasisClinical Microbiology Reviews, 2001
- An open-label clinical study of nitazoxanide in the treatment of human fascioliasisCurrent Therapeutic Research, 2000
- Syntheses and Antibacterial Activities of Tizoxanide, an N-(Nitrothiazolyl)salicylamide, and its O-Aryl GlucuronideJournal of Chemical Research, 1999
- Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in egyptCurrent Therapeutic Research, 1998
- Severe Giardiasis in the United StatesClinical Infectious Diseases, 1994
- Evaluation of New Anti-Infective Drugs for the Treatment of Diarrhea Caused by Giardia lambliaClinical Infectious Diseases, 1992
- Timing of Symptoms and Oocyst Excretion in Human CryptosporidiosisNew England Journal of Medicine, 1986